| Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy A Biffi, E Montini, L Lorioli, M Cesani, F Fumagalli, T Plati, C Baldoli, ... Science 341 (6148), 1233158, 2013 | 1377 | 2013 |
| Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial M Sessa, L Lorioli, F Fumagalli, S Acquati, D Redaelli, C Baldoli, ... The Lancet 388 (10043), 476-487, 2016 | 491 | 2016 |
| Stem cell-biomaterial interactions for regenerative medicine S Martino, F D'Angelo, I Armentano, JM Kenny, A Orlacchio Biotechnology advances 30 (1), 338-351, 2012 | 269 | 2012 |
| In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice A Consiglio, A Quattrini, S Martino, JC Bensadoun, D Dolcetta, A Trojani, ... Nature medicine 7 (3), 310-316, 2001 | 234 | 2001 |
| Identification of hematopoietic stem cell–specific miRNAs enables gene therapy of globoid cell leukodystrophy B Gentner, I Visigalli, H Hiramatsu, E Lechman, S Ungari, A Giustacchini, ... Science translational medicine 2 (58), 58ra84-58ra84, 2010 | 227 | 2010 |
| PVA bio-nanocomposites: A new take-off using cellulose nanocrystals and PLGA nanoparticles N Rescignano, E Fortunati, S Montesano, C Emiliani, JM Kenny, ... Carbohydrate Polymers 99, 47-58, 2014 | 162 | 2014 |
| Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded … F Fumagalli, V Calbi, MGN Sora, M Sessa, C Baldoli, PMV Rancoita, ... The Lancet 399 (10322), 372-383, 2022 | 147 | 2022 |
| Insight into mechanobiology: how stem cells feel mechanical forces and orchestrate biological functions C Argentati, F Morena, I Tortorella, M Bazzucchi, S Porcellati, C Emiliani, ... International journal of molecular sciences 20 (21), 5337, 2019 | 113 | 2019 |
| Nanocomposites based on biodegradable polymers I Armentano, D Puglia, F Luzi, CR Arciola, F Morena, S Martino, L Torre Materials 11 (5), 795, 2018 | 113 | 2018 |
| Tuning Multi/Pluri-Potent Stem Cell Fate by Electrospun Poly(l-lactic acid)-Calcium-Deficient Hydroxyapatite Nanocomposite Mats F D’Angelo, I Armentano, I Cacciotti, R Tiribuzi, M Quattrocelli, ... Biomacromolecules 13 (5), 1350-1360, 2012 | 99 | 2012 |
| Adipose stem cell translational applications: from bench-to-bedside C Argentati, F Morena, M Bazzucchi, I Armentano, C Emiliani, S Martino International journal of molecular sciences 19 (11), 3475, 2018 | 91 | 2018 |
| A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay–Sachs disease S Martino, P Marconi, B Tancini, D Dolcetta, MGC De Angelis, ... Human molecular genetics 14 (15), 2113-2123, 2005 | 90 | 2005 |
| Carbon nanotubes and silver nanoparticles for multifunctional conductive biopolymer composites E Fortunati, F D’angelo, S Martino, A Orlacchio, JM Kenny, I Armentano Carbon 49 (7), 2370-2379, 2011 | 87 | 2011 |
| Micropatterned hydrogenated amorphous carbon guides mesenchymal stem cells towards neuronal differentiation F D’angelo, I Armentano, S Mattioli, L Crispoltoni, R Tiribuzi, GG Cerulli, ... Eur Cell Mater 20 (4), 231-244, 2010 | 86 | 2010 |
| MicroRNA implications across neurodevelopment and neuropathology S Martino, I Di Girolamo, A Orlacchio, A Datti, A Orlacchio BioMed Research International 2009 (1), 654346, 2009 | 85 | 2009 |
| Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models A Lattanzi, M Neri, C Maderna, I Di Girolamo, S Martino, A Orlacchio, ... Human molecular genetics 19 (11), 2208-2227, 2010 | 84 | 2010 |
| Hydrogenated amorphous carbon nanopatterned film designs drive human bone marrow mesenchymal stem cell cytoskeleton architecture S Martino, F D'Angelo, I Armentano, R Tiribuzi, M Pennacchi, M Dottori, ... Tissue Engineering Part A 15 (10), 3139-3149, 2009 | 78 | 2009 |
| Generation of human induced pluripotent stem cell-derived bona fide neural stem cells for ex vivo gene therapy of metachromatic leukodystrophy V Meneghini, G Frati, D Sala, S De Cicco, M Luciani, C Cavazzin, ... Stem Cells Translational Medicine 6 (2), 352-368, 2017 | 75 | 2017 |
| Neural stem cell gene therapy ameliorates pathology and function in a mouse model of globoid cell leukodystrophy M Neri, A Ricca, I di Girolamo, B Alcala'-Franco, C Cavazzin, A Orlacchio, ... Stem cells 29 (10), 1559-1571, 2011 | 74 | 2011 |
| Combined gene/cell therapies provide long-term and pervasive rescue of multiple pathological symptoms in a murine model of globoid cell leukodystrophy A Ricca, N Rufo, S Ungari, F Morena, S Martino, W Kulik, V Alberizzi, ... Human molecular genetics 24 (12), 3372-3389, 2015 | 70 | 2015 |
